JP2005000033A - Food - Google Patents
Food Download PDFInfo
- Publication number
- JP2005000033A JP2005000033A JP2003165298A JP2003165298A JP2005000033A JP 2005000033 A JP2005000033 A JP 2005000033A JP 2003165298 A JP2003165298 A JP 2003165298A JP 2003165298 A JP2003165298 A JP 2003165298A JP 2005000033 A JP2005000033 A JP 2005000033A
- Authority
- JP
- Japan
- Prior art keywords
- food
- coenzyme
- epa
- dha
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は食品に関する。さらに詳細には、抗酸化作用、老化の抑制、運動能力の向上、疲労回復、肌の若返り、滋養強壮、強精、妊娠促進効果を有し、月経不順、更年期障害、冷え、むくみ、便秘などを解消し、血液をサラサラにする善玉コレステロールが増えて、ドロドロの原因になる血中の中性脂肪を減少させ得る成分を含む保健栄養食品に関する。
【0002】
【従来の技術】
最近、「セルフメディケーション」つまり自分の責任のもと、自分の健康を維持し、管理していくという新しい概念が提唱され、既に高齢化社会が始まっている現在、老化を遅らせ、加齢とともに起き易い疾病の予防となる可能性の高い食品が求められている。
【0003】
【発明が解決しようとする課題】
本発明の目的は、老化を遅らせ、加齢とともに起き易い疾病を予防し得る食品を提供することである。
本発明の他の目的は、抗酸化作用、老化の抑制、運動能力の向上、疲労回復、肌の若返り、滋養強壮、強精、妊娠促進効果を有し、月経不順、更年期障害、冷え、むくみ、便秘などを解消し、血液をサラサラにする善玉コレステロールが増えて、ドロドロの原因になる血中の中性脂肪を減少させ得る成分を含む保健栄養食品を提供することである。
【0004】
【課題を解決するための手段】
本発明は以下の食品を提供するものである。
1.補酵素Q、マカエキスパウダー、及びDHA及び/又はEPAを含む食品。
2.補酵素Q、マカエキスパウダー、及びDHA及び/又はEPA含有魚油を含む食品。
3.補酵素Qが補酵素Q10である上記1又は2記載の食品。
4.さらにビタミンEを含む上記1〜3のいずれか1項記載の食品。
【0005】
【発明の実施の形態】
本発明の第1の成分として使用する補酵素Q、特に補酵素Q10は、サプリメント大国である米国において身体のエネルギー生産が高まり元気が沸くという評判で、「スペシャリティーサプリメント」分野で1995年以来常にトップ5に入る売り上げを誇る人気栄養食品となっている。日本においては1974年に鬱血性心不全等の心臓病に対する治療薬として認可を受け医薬品として使用されてきている。2001年3月の厚生労働省の食薬区分改正により食品として使用することが可能となった。補酵素Q10は、もともと体内に存在し細胞内のエネルギー産生に関与する重要な成分で抗酸化作用もあり活性酸素から身体を守る重要な役割も果たしている。補酵素Q10は、生体内で合成することが可能であるが、一般的に20歳をピークにその産生能力は低下し、50歳以上の人では多くの人が不足状態にあり、外部からの補給が有効といわれている。また、日常の食事からはわずかな量しか補給できない点で、本発明の食品の成分として重要である。
補酵素Q10の期待できる作用としては、抗酸化作用、老化の抑制、運動能力の向上、疲労回復、肌の若返りなどである。
補酵素Qはユビキノンtも呼ばれ、補酵素Q6〜10が知られている。本発明には補酵素Q6〜10のいずれも使用できる。
【0006】
本発明の第2の成分として使用するマカエキスパウダーは、南米ペルー原産の植物であるマカエキスを粉末化したものである。マカエキスパウダーは「アンデスニンジン」とも呼ばれ古くは一部の特権階級しか食べることのできなかった貴重な食品である。マカエキスパウダーは滋養強壮、強精、妊娠促進効果にすぐれ、月経不順や更年期障害、冷え、むくみ、便秘などを解消するといわれている。
その多彩な効果の理由は、炭水化物やたんぱく質、ビタミンB群、ビタミンEのほか、カルシウム、鉄分、ヨードなどのミネラル類が豊富に含まれている点にあるのではないかといわれている。
数年前からドイツやフランス、アメリカなどの研究機関が、不妊症や冷感症、EDなどの治療のため、マカによる治療を続けていることが報告されている。
【0007】
本発明の第3の成分であるDHA(ドコサヘキサエン酸)、EPA(エイコサペンタエン酸)は、DHA及び/又はEPA自体を使用しても良いし、これを豊富に含む魚油の形態で使用しても良い。イワシ、マグロ等の青魚に多く含まれるDHAやEPAは、血小板の凝集を抑える物質の原料となり、毎日摂取をし続けると、血液をサラサラにする善玉コレステロールが増えて、ドロドロの原因になる血中の中性脂肪が減ることがヒトでの実験で確認されている。さらに、赤血球などの細胞膜に入り込み、膜を柔軟にする効果も確認されている。
【0008】
本発明は上記3成分を必須の成分とするが、さらに第4の成分としてビタミンEを含むことが望ましい。ビタミンEは、原料の酸化防止剤としての機能を有する。
本発明の食品中、補酵素Qの含有量は、好ましくは15〜25質量%、さらに好ましくは18〜22質量%、マカエキスパウダーの含有量は、好ましくは15〜25質量%、さらに好ましくは18〜22質量%、DHA及び/又はEPAの含有量は、好ましくは12〜20質量%、さらに好ましくは14〜18質量%、従って例えば、これを30〜40質量%含有する魚油として、好ましくは40〜67質量%、さらに好ましくは48〜58質量%である。ビタミンEの含有量は、好ましくは2〜10質量%、さらに好ましくは4〜6質量%である。
【0009】
本発明の食品は、上記成分を混合することにより容易に製造できる。通常は、補酵素Q及びマカエキスパウダーは固体であり、DHA及び/又はEPAを含む魚油及びビタミンEは油であるので全成分を混合し、任意の形状に成型すれば良い。
このとき、増粘剤として、米から抽出されたライスワックスや、蜜蝋等を添加しても良い。増粘剤の添加量は好ましくは4〜10質量%、さらに好ましくは6〜8質量%である。
【0010】
本発明の食品の形態は特に制限されず、錠剤、液剤、カプセル剤、等任意の形態とすることができる。錠剤又はカプセル剤としておくことにより、食品の取扱や経口摂取がより容易になる。
錠剤とする場合には、ゼラチン、グリセリン等の被覆材料で錠剤表面をコーティングしておくことが望ましい。
あるいは、カプセル剤としても良い。カプセルの皮膜材料としては、ゼラチンが一般的である。
【0011】
本発明の食品は、1錠剤、又は1カプセル中に補酵素Qを、好ましくは30〜70mg、さらに好ましくは40〜60mg、通常は約50mg、マカエキスパウダーを、好ましくは30〜70mg、さらに好ましくは40〜60mg、通常は約50mg、DHA及び/又はEPAを30〜40質量%含有する魚油を好ましくは100〜160mg、さらに好ましくは115〜145mg、通常は約130mg、ビタミンEを好ましくは7〜13mg、さらに好ましくは9〜11mg、通常は約10mgを含有させることが望ましい。
摂取量は、大人で1日に上記錠剤又はカプセルを1〜4個、通常は2個程度が適当であり、毎日摂取することにより、所期の目的が達成される。例えば、1日2個摂取する場合、朝と夕の2回とすれば良い。
【0012】
【発明の効果】
本発明の食品は、経口摂取することにより、抗酸化作用、老化の抑制、運動能力の向上、疲労回復、肌の若返り、滋養強壮、強精、妊娠促進効果を奏し、月経不順、更年期障害、冷え、むくみ、便秘などを解消し、血液をサラサラにする善玉コレステロールが増えて、ドロドロの原因になる血中の中性脂肪を減少させ得る。
【0013】
【実施例】
補酵素Q10を50g、マカエキスパウダーを50g、DHA及び/又はEPAを含有するマグロ抽出油を132g(DHA含有量:35.6g、EPA含有量:6.6g)、ビタミンEを28g良く混合し、これをゼラチンとグリセリンからなるソフトカプセルで包み、1粒の質量が420mg(補酵素Q10を50mg、マカエキスパウダーを50mg、DHA及びEPAを含有するマグロ抽出油を132mg(DHA:35.64mg、EPA:6.6mg)、ビタミンEを28mg含む)のソフトカプセル1000個を製造した。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to food. More specifically, it has anti-oxidant action, suppression of aging, improvement of exercise ability, recovery from fatigue, skin rejuvenation, nourishing tonicity, toughness, pregnancy promotion effect, irregular menstruation, menopause, coldness, swelling, constipation, etc. It is related to health and nutritional foods that contain components that can reduce the neutral fat in the blood that increases the amount of good cholesterol that makes the blood smoother and causes muddyness.
[0002]
[Prior art]
Recently, a new concept of “self-medication”, that is, maintaining and managing one's own health under the responsibility of oneself, has been advocated, and the aging society has already begun. There is a need for foods that are likely to prevent prevalent diseases.
[0003]
[Problems to be solved by the invention]
An object of the present invention is to provide a food that can delay aging and prevent diseases that are likely to occur with aging.
Other objects of the present invention are antioxidant, suppression of aging, improvement of exercise ability, recovery from fatigue, skin rejuvenation, nourishing tonicity, toughness, pregnancy promotion effect, irregular menstruation, menopause, cooling, swelling It is to provide health and nutritional foods that contain ingredients that can eliminate constipation, increase the amount of good cholesterol that makes blood smooth, and reduce the neutral fat in the blood that causes muddyness.
[0004]
[Means for Solving the Problems]
The present invention provides the following foods.
1. A food containing coenzyme Q, maca extract powder, and DHA and / or EPA.
2. A food containing coenzyme Q, maca extract powder, and fish oil containing DHA and / or EPA.
3. 3. The food according to 1 or 2 above, wherein the coenzyme Q is coenzyme Q10.
4). Furthermore, the foodstuff of any one of said 1-3 containing vitamin E.
[0005]
DETAILED DESCRIPTION OF THE INVENTION
The coenzyme Q used as the first component of the present invention, particularly coenzyme Q10, has a reputation for boosting energy production in the body in the United States, which is a major supplement nation, and has always been well-being. It is a popular nutrition food that boasts the top 5 sales. In Japan, in 1974, it was approved as a therapeutic drug for heart diseases such as congestive heart failure and has been used as a pharmaceutical product. In March 2001, the Ministry of Health, Labor and Welfare revised the food category, making it possible to use it as food. Coenzyme Q10 is an important component that originally exists in the body and is involved in the production of energy in the cell, and has an antioxidant action and also plays an important role in protecting the body from active oxygen. Coenzyme Q10 can be synthesized in vivo, but its production capacity generally declines at the peak of 20 years old, and many people over 50 years old are in a deficient state. It is said that replenishment is effective. Further, it is important as a component of the food of the present invention in that only a small amount can be replenished from a daily meal.
Expected actions of coenzyme Q10 include antioxidant action, suppression of aging, improvement of exercise ability, recovery from fatigue, skin rejuvenation, and the like.
Coenzyme Q is also called ubiquinone t, and coenzymes Q6 to 10 are known. Any of coenzymes Q6-10 can be used in the present invention.
[0006]
The maca extract powder used as the second component of the present invention is a powdered maca extract, a plant native to Peru, South America. Maca extract powder, also called “Andean carrot”, is a precious food that only some privileged classes could eat. Maca extract powder is said to be excellent in nourishing tonic, strong, and pregnancy-promoting effects, and to eliminate irregular menstruation, menopause, coldness, swelling, and constipation.
It is said that the reason for its various effects is that it contains abundant minerals such as calcium, iron, and iodine in addition to carbohydrates, proteins, vitamin B group and vitamin E.
It has been reported that research institutions such as Germany, France, and the United States have continued treatment with maca for treatment of infertility, cold sensation and ED for several years.
[0007]
DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), which are the third component of the present invention, may use DHA and / or EPA itself, or may be used in the form of fish oil rich in this. good. DHA and EPA, which are abundant in blue fish such as sardines and tuna, are used as raw materials for substances that suppress platelet aggregation. It has been confirmed by human experiments that triglycerides are reduced. In addition, it has been confirmed that it penetrates into cell membranes such as erythrocytes and softens the membrane.
[0008]
In the present invention, the above three components are essential components, but it is desirable that vitamin E is further contained as the fourth component. Vitamin E functions as a raw material antioxidant.
In the food of the present invention, the content of coenzyme Q is preferably 15 to 25% by mass, more preferably 18 to 22% by mass, and the content of maca extract powder is preferably 15 to 25% by mass, and more preferably 18%. -22% by weight, DHA and / or EPA content is preferably 12-20% by weight, more preferably 14-18% by weight, thus for example as fish oil containing 30-40% by weight, preferably 40 It is -67 mass%, More preferably, it is 48-58 mass%. The content of vitamin E is preferably 2 to 10% by mass, more preferably 4 to 6% by mass.
[0009]
The foodstuff of this invention can be easily manufactured by mixing the said component. Usually, coenzyme Q and maca extract powder are solid, and fish oil and vitamin E containing DHA and / or EPA are oils. Therefore, all components may be mixed and molded into an arbitrary shape.
At this time, rice wax extracted from rice, beeswax or the like may be added as a thickener. The addition amount of the thickener is preferably 4 to 10% by mass, more preferably 6 to 8% by mass.
[0010]
The form of the food of the present invention is not particularly limited, and may be any form such as a tablet, liquid, capsule, and the like. By setting it as a tablet or a capsule, handling and oral intake of food become easier.
In the case of a tablet, it is desirable to coat the tablet surface with a coating material such as gelatin or glycerin.
Or it is good also as a capsule. As a capsule coating material, gelatin is generally used.
[0011]
The food of the present invention contains coenzyme Q in one tablet or capsule, preferably 30 to 70 mg, more preferably 40 to 60 mg, usually about 50 mg, maca extract powder, preferably 30 to 70 mg, more preferably 40-60 mg, usually about 50 mg, fish oil containing 30-40% by weight of DHA and / or EPA, preferably 100-160 mg, more preferably 115-145 mg, usually about 130 mg, vitamin E preferably 7-13 mg More preferably, it is desirable to contain 9 to 11 mg, usually about 10 mg.
Ingestion is appropriately 1 to 4, usually 2 of the above tablets or capsules per day for an adult, and the intended purpose is achieved by taking it daily. For example, when taking two daily doses, it may be twice in the morning and evening.
[0012]
【The invention's effect】
The food of the present invention, when taken orally, has an antioxidant effect, suppression of aging, improvement of exercise ability, fatigue recovery, skin rejuvenation, nourishing tonicity, strong fertility, pregnancy promotion effect, irregular menstruation, menopause, It can eliminate cold, swelling, constipation, etc., increase the good cholesterol that makes the blood smooth, and reduce the neutral fat in the blood that causes muddy.
[0013]
【Example】
50 g of coenzyme Q10, 50 g of maca extract powder, 132 g of tuna extract oil containing DHA and / or EPA (DHA content: 35.6 g, EPA content: 6.6 g), and 28 g of vitamin E are mixed well. This is wrapped in a soft capsule made of gelatin and glycerin, and the mass of one grain is 420 mg (coenzyme Q10 50 mg, maca extract powder 50 mg, tuna extract oil containing DHA and EPA 132 mg (DHA: 35.64 mg, EPA: 6 6 mg) and 1000 soft capsules containing 28 mg of vitamin E).
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003165298A JP2005000033A (en) | 2003-06-10 | 2003-06-10 | Food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003165298A JP2005000033A (en) | 2003-06-10 | 2003-06-10 | Food |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005000033A true JP2005000033A (en) | 2005-01-06 |
Family
ID=34091821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003165298A Pending JP2005000033A (en) | 2003-06-10 | 2003-06-10 | Food |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2005000033A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007314475A (en) * | 2006-05-26 | 2007-12-06 | Kao Corp | Agent for suppressing triacylglycerol synthesis |
EP1897530A1 (en) * | 2006-09-08 | 2008-03-12 | DSMIP Assets B.V. | Skin care composition |
KR100822608B1 (en) * | 2006-12-28 | 2008-04-16 | 주식회사 하이닉스반도체 | Device Separation Method of Semiconductor Memory Device |
KR100822609B1 (en) * | 2006-12-28 | 2008-04-16 | 주식회사 하이닉스반도체 | Device Separator Formation Method of Semiconductor Device |
JP2009523414A (en) * | 2005-12-21 | 2009-06-25 | ブルーディ、テクノロジー、ソシエダッド、リミターダ | Use of DHA, EPA or DHA-derived EPA to treat lesions associated with oxidative damage of cells |
JP2014028830A (en) * | 2005-12-21 | 2014-02-13 | Brudy Technology Sl | Use of dha, epa or dha-derived epa for treating pathology associated with cellular oxidative damage |
CN103829237A (en) * | 2014-02-11 | 2014-06-04 | 毛庆云 | Nourishing health-care buccal tablet and preparation method thereof |
CN103989185A (en) * | 2014-06-12 | 2014-08-20 | 宁波市成大机械研究所 | Deep sea fish oil soft capsule containing coenzyme Q |
CN104274810A (en) * | 2014-10-13 | 2015-01-14 | 徐鸿刚 | Traditional Chinese medicine composition for treating irregular menstruation and preparation method of traditional Chinese medicine composition |
-
2003
- 2003-06-10 JP JP2003165298A patent/JP2005000033A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014028830A (en) * | 2005-12-21 | 2014-02-13 | Brudy Technology Sl | Use of dha, epa or dha-derived epa for treating pathology associated with cellular oxidative damage |
JP2009523414A (en) * | 2005-12-21 | 2009-06-25 | ブルーディ、テクノロジー、ソシエダッド、リミターダ | Use of DHA, EPA or DHA-derived EPA to treat lesions associated with oxidative damage of cells |
JP2007314475A (en) * | 2006-05-26 | 2007-12-06 | Kao Corp | Agent for suppressing triacylglycerol synthesis |
WO2008028634A1 (en) * | 2006-09-08 | 2008-03-13 | Dsm Ip Assets B.V. | Skin care composition |
WO2008028631A3 (en) * | 2006-09-08 | 2008-06-05 | Dsm Ip Assets Bv | Skin care composition |
WO2008028635A1 (en) * | 2006-09-08 | 2008-03-13 | Dsm Ip Assets B.V. | Skin care composition |
JP2010502662A (en) * | 2006-09-08 | 2010-01-28 | ディーエスエム アイピー アセッツ ビー.ブイ. | Skin care composition |
EP1897530A1 (en) * | 2006-09-08 | 2008-03-12 | DSMIP Assets B.V. | Skin care composition |
KR100822608B1 (en) * | 2006-12-28 | 2008-04-16 | 주식회사 하이닉스반도체 | Device Separation Method of Semiconductor Memory Device |
KR100822609B1 (en) * | 2006-12-28 | 2008-04-16 | 주식회사 하이닉스반도체 | Device Separator Formation Method of Semiconductor Device |
CN103829237A (en) * | 2014-02-11 | 2014-06-04 | 毛庆云 | Nourishing health-care buccal tablet and preparation method thereof |
CN103989185A (en) * | 2014-06-12 | 2014-08-20 | 宁波市成大机械研究所 | Deep sea fish oil soft capsule containing coenzyme Q |
CN104274810A (en) * | 2014-10-13 | 2015-01-14 | 徐鸿刚 | Traditional Chinese medicine composition for treating irregular menstruation and preparation method of traditional Chinese medicine composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU780504B2 (en) | Nutritional supplements | |
JP5574561B2 (en) | Total enteral nutrition composition | |
JP3512198B2 (en) | Two-phase preparation | |
JPS63310822A (en) | Medicine and diet food for normalizing blood coagulation | |
WO2005060954A1 (en) | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof | |
US11576935B2 (en) | Non-winterized, standardized marine source oil products and methods of making thereof | |
JPH0394655A (en) | Nutrient feeding composition | |
JP2005000033A (en) | Food | |
JP2003169632A (en) | Health food containing rice germ oil, yolk oil and phosphatidylserine | |
MXPA05010930A (en) | Multi-vitamin and mineral supplement for pregnant women. | |
JPS6115647A (en) | Oil and fat food | |
JP2002360220A (en) | Health supplement food having improving action for interruption in circulation of blood | |
JPS62224258A (en) | Nourishing food | |
WO2014134834A1 (en) | Composition and food comprising same and preparation method of food | |
Larsen | Fish oils: The essential nutrients | |
JP4997514B2 (en) | Antihypertensive agent | |
RU2351350C1 (en) | Set "predstar", its application and method of prevention of premature organism aging | |
US20180110748A1 (en) | Composition for reducing or suppressing increase in neutral fat level containing n-3 unsaturated fatty acid, and use of n-3 unsaturated fatty acid in production of same composition | |
AU2019352938A1 (en) | Nutrition-based support for the body's own wound healing processes | |
JP2018168139A (en) | Composition for reducing or increasing neutral fat value containing n-3 unsaturated fatty acid, and use of n-3 unsaturated fatty acid in the production of the composition | |
McLennan et al. | Omega-3 fatty acids for cardiovascular protection | |
JPS6115649A (en) | Oily food | |
TWM451971U (en) | Capsule structure containing vegetable unsaturated fatty acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050603 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051121 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060120 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060220 |